Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization
Clinical trial NCT03042871 · COMPLETED
Trial details
- NCT number
- NCT03042871
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2018-07-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.